AlphaYouKVYO: Hallen Ed discloses a sale
By AlphaYouPublished Form 4
Hallen Ed
Reporting filer
Hallen Ed reported Sale in Klaviyo, Inc.: 500 units of Series A Common Stock, dated 2026-09-24. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 25, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Series A Common Stock | Hallen Ed | 2026-09-24 | S | Sale | 500 | 17.02 | 93,957 | 1 day | Filed terms
|
| Series A Common Stock | Hallen Ed | 2026-09-24 | S | Sale | 800 | 17.02 | 446,946 | 1 day | Filed terms
|
Series A Common Stock
- Owner
- Hallen Ed
- Date
- 2026-09-24
- Code
- S
- Action
- Sale
- Quantity
- 500
- Price
- 17.02
- Following holdings
- 93,957
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Series A Common Stock
- transaction Date: 2026-09-24
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 500
- transaction Price Per Share: 17.02
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 93957
- direct Or Indirect Ownership: I
- nature Of Ownership: By Hodgkins Trust
- id: F3
Series A Common Stock
- Owner
- Hallen Ed
- Date
- 2026-09-24
- Code
- S
- Action
- Sale
- Quantity
- 800
- Price
- 17.02
- Following holdings
- 446,946
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Series A Common Stock
- transaction Date: 2026-09-24
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 800
- transaction Price Per Share: 17.02
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 446946
- direct Or Indirect Ownership: I
- nature Of Ownership: By Hodgkins LLC
- id: F4
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Hallen Ed: Director, 10% owner.
- The filing reports a Rule 10b5-1 trading plan.
- F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026.
- F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.00 to $17.03 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3: Shares are owned directly by Hodgkins Trust for the benefit of the Reporting Person and the Reporting Person's family, and of which the trustee is an independent institution. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- F4: Shares held by Hodgkins LLC, of which the Reporting Person serves as manager. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
Original sources
Prepared automatically from public filing data. Report a correction.